LivaNova Appoints Donald Zurbay to Board of Directors

LIVN
September 20, 2025
LivaNova PLC announced the appointment of Donald (Don) Zurbay to the Company’s Board of Directors, effective September 4, 2025. Zurbay will serve on the Audit and Compliance Committee for the Board. He brings over 30 years of expertise in finance, accounting, and strategy, much of which was gained in leadership positions with global healthcare companies. Zurbay previously served as President and Chief Executive Officer, and prior to that, Chief Financial Officer, at Patterson Companies, Inc., a global healthcare company. He also spent nearly 13 years at St. Jude Medical, a global medical device company, in various leadership roles, including CFO. His extensive experience and knowledge are expected to be valuable assets to the Board, supporting the company's mission to improve quality of life for patients and drive value for shareholders. With this appointment, the LivaNova Board is now comprised of 11 Directors, enhancing its collective expertise. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.